amifostine anhydrous has been researched along with chitosan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bostanian, LA; Graves, RA; Kishore, V; Mandal, TK; Moiseyev, R; Pamujula, S | 1 |
| Gangenahalli, G; Gupta, S | 1 |
2 other study(ies) available for amifostine anhydrous and chitosan
| Article | Year |
|---|---|
Preparation of polylactide-co-glycolide and chitosan hybrid microcapsules of amifostine using coaxial ultrasonic atomizer with solvent evaporation.
Topics: Administration, Oral; Amifostine; Biological Availability; Capsules; Cations; Chitosan; Delayed-Action Preparations; Drug Carriers; Methylene Chloride; Nebulizers and Vaporizers; Particle Size; Phosphatidylcholines; Polyglactin 910; Radiation-Protective Agents; Solvents | 2008 |
Vascular Cell Adhesion Molecule 1-Mediated Targeting of Human Hematopoietic Stem Cells to Bone Marrow Is Effective in Conferring Regeneration and Survival in Lethally Irradiated Mice.
Topics: Amifostine; Animals; Biocompatible Materials; Bone Marrow; Chitosan; Cytokines; Endothelial Cells; Hematopoietic Stem Cells; Humans; Liposomes; Mice; Vascular Cell Adhesion Molecule-1 | 2022 |